Abstract
We report 2 cases of recurrent Campylobacter coli enteritis caused by macrolide- and fluoroquinolone-resistant strains in 2 patients with hypogammaglobulinemia, successfully treated with a prolonged course of fosfomycin-tromethamine with no side effects. Fosfomycin-tromethamine may be a feasible alternative therapy for recurrent enteritis caused by Campylobacter species resistant to first-line drugs.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.
MeSH terms
-
Agammaglobulinemia / drug therapy
-
Aged, 80 and over
-
Anti-Bacterial Agents / therapeutic use*
-
Campylobacter / drug effects*
-
Campylobacter / pathogenicity*
-
Enteritis / drug therapy*
-
Female
-
Fosfomycin / therapeutic use*
-
Humans
-
Microbial Sensitivity Tests
-
Middle Aged
-
Tromethamine / therapeutic use*
Substances
-
Anti-Bacterial Agents
-
Tromethamine
-
Fosfomycin
Grants and funding
This research received no specific grant from any funding agency in the public, commercial, or nonprofit sectors.